TY - JOUR AU - Coghill, David R AU - Banaschewski, Tobias AU - Lecendreux, Michel AU - Zuddas, Alessandro AU - Dittmann, Ralf W AU - Hernández Otero, Isabel AU - Civil, Richard AU - Bloomfield, Ralph AU - Squires, Liza A PY - 2014 DO - 10.1007/s00787-013-0421-y SN - 1018-8827 UR - http://hdl.handle.net/10668/1552 T2 - European child & adolescent psychiatry AB - Lisdexamfetamine dimesylate (LDX) is a long-acting, prodrug stimulant therapy for patients with attention-deficit/hyperactivity disorder (ADHD). This randomized placebo-controlled trial of an optimized daily dose of LDX (30, 50 or 70 mg) was conducted... LA - en PB - Springer Verlag KW - ADHD KW - Lisdexamfetamine dimesylate KW - Randomized controlled trial KW - Central nervous system stimulants KW - Maintenance of efficacy KW - Conners’ parent rating scale KW - Estimulantes del sistema nervioso central KW - Conducta del adolescente KW - Trastorno por déficit de atención con hiperactividad KW - Anfetaminas KW - Resultado del tratamiento KW - Ensayo clínico controlado aleatorio KW - Dextroanfetamina KW - Niño KW - Adolescente KW - Medical Subject Headings::Psychiatry and Psychology::Mental Disorders::Mental Disorders Diagnosed in Childhood::Attention Deficit and Disruptive Behavior Disorders::Attention Deficit Disorder with Hyperactivity KW - Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amines::Ethylamines::Phenethylamines::Amphetamines KW - Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Central Nervous System Stimulants KW - Medical Subject Headings::Named Groups::Persons::Age Groups::Child KW - Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans KW - Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amines::Ethylamines::Phenethylamines::Amphetamines::Amphetamine::Dextroamphetamine KW - Medical Subject Headings::Psychiatry and Psychology::Behavior and Behavior Mechanisms::Behavior::Adolescent Behavior KW - Medical Subject Headings::Health Care::Health Services Administration::Quality of Health Care::Outcome and Process Assessment (Health Care)::Outcome Assessment (Health Care)::Treatment Outcome KW - Medical Subject Headings::Publication Characteristics::Study Characteristics::Clinical Trial::Randomized Controlled Trial KW - Medical Subject Headings::Named Groups::Persons::Age Groups::Adolescent TI - Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial. TY - research article ER -